# Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow

> **NCT02145286** · NA · UNKNOWN · sponsor: **Paul W. Read, MD** · enrollment: 47 (estimated)

## Conditions studied

- Metastatic Bone Lesion

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT02145286
- **Lead sponsor:** Paul W. Read, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2018-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145286, "Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02145286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*